1. Cost-benefit and cost-effectiveness: methodologies for evaluating innovative pharmaceutical services;McGhan;Am J Hosp Pharm,1978
2. Individualizing gentamicin dosage regimens on burn patients with gram-negative septicemia: a cost-benefit analysis;Bootman;J Pharm Sci,1979
3. Post marketing drug research and development: an industry clinical pharmacist's perspective;Townsend;Am J Pharm Educ,1986
4. Using pharmacoeconomic analysis to make drug insurance coverage decisions;Anis;Pharmacoeconomics,1998
5. Applying the Australian Guidelines for the subsidization of pharmaceuticals;Aristides;Pharmacoeconomics,1994